Atrial Fibrillation
December 2022 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Atrial Fibrillation abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Atrial Fibrillation. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Atrial Fibrillation. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Atrial Fibrillation every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues.
Authors:Matusik PT, Heleniak Z, Undas A
Institution:The John Paul II Hospital, Krakow, Poland; Department of Electrocardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.; The John Paul II Hospital, Krakow, Poland; Department of Thromboembolic Diseases, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Journal:Anatol J Cardiol. 2022 Dec;26(12):857-863. doi: 10.5152/AnatolJCardiol.2022.2426.

2:Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions.
Authors:Gómez-Outes A, Suárez-Gea ML, Pérez-Cabeza AI, García-Pinilla JM
Institution:Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.; Servicio de Cardiologia, Hospital Universitario Virgen de la Victoria, Instituto de Biomedicina de Malaga (IBIMA), Malaga, Spain.
Journal:Expert Opin Pharmacother. 2022 Dec;23(17):1941-1955. doi: 10.1080/14656566.2022.2149323. Epub 2022 Nov 27.

3:Promising Therapies for Atrial Fibrillation and Ventricular Tachycardia.
Authors:Mircea AA, Rusu M, Liehn EA, Bucur O
Institution:Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.
Journal:Int J Mol Sci. 2022 Oct 20;23(20):12612. doi: 10.3390/ijms232012612.

4:What is the Best Agent for Rate Control of Atrial Fibrillation With Rapid Ventricular Response?
Authors:Long B, Keim SM, Gottlieb M, Stiell IG
Institution:Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas.; Department of Emergency Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Journal:J Emerg Med. 2022 Sep;63(3):467-476. doi: 10.1016/j.jemermed.2022.07.014. Epub 2022 Oct 11.

5:Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis.
Authors:Jia X, Yin Z, Zhang W, Du S, Kang J
Institution:Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, 43 North University Road, Zhengzhou City, 450052, Henan Province, China. jiaxd.zzu@163.com.; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, 43 North University Road, Zhengzhou City, 450052, Henan Province, China. 2455232597@qq.com.
Journal:J Transl Med. 2022 Sep 30;20(1):441. doi: 10.1186/s12967-022-03652-9.

6:Cryoablation as a first-line therapy for atrial fibrillation: current status and future prospects.
Authors:Andrade JG, Deyell MW, Dubuc M, Macle L
Institution:Montreal Heart Institute, Department of Medicine, Universite de Montreal, Montreal, Quebec, Canada.
Journal:Expert Rev Med Devices. 2022 Aug;19(8):623-631. doi: 10.1080/17434440.2022.2129008. Epub 2022 Oct 3.

7:Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse.
Authors:Ktenopoulos N, Sagris M, Theofilis P, Lionaki S, Rallidis LS
Institution:Internal Medicine Department, Konstantopoulio General Hospital, 14233 Athens, Attica Province, Greece.; Second Department of Cardiology, University General Hospital, 'Attikon', Athens, National and Kapodistrian University of Athens, 11527 Athens, Attica Province, Greece.
Journal:Front Biosci (Schol Ed). 2022 Jul 21;14(3):21. doi: 10.31083/j.fbs1403021.

8:Comparison of Effectiveness and Safety between High-Power Short-Duration Ablation and Conventional Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Authors:Jin S, Fu L, Jiang J, Ye X, Liu H, Chen Y, Pu S, Wu S, Xue Y
Institution:Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Journal:J Interv Cardiol. 2022 Aug 16;2022:6013474. doi: 10.1155/2022/6013474. eCollection 2022.

9:The complex interplay between diabetes mellitus and atrial fibrillation.
Authors:Yildiz M, Lavie CJ, Morin DP, Oktay AA
Institution:The Carl and Edyth Lindner Center for Research and Education, The Christ Hospital, Cincinnati, Ohio, USA.; The Heart and Vascular Institute, Rush University Medical Center, Chicago, Illinois, USA.
Journal:Expert Rev Cardiovasc Ther. 2022 Sep;20(9):707-717. doi: 10.1080/14779072.2022.2115357. Epub 2022 Aug 25.

10:Atrial Fibrillation and Stress: A 2-Way Street?
Authors:Segan L, Prabhu S, Kalman JM, Kistler PM
Institution:The Alfred Hospital, Melbourne, Australia; Baker Heart and Diabetes Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia.; The Alfred Hospital, Melbourne, Australia; Baker Heart and Diabetes Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne, Australia. Electronic address: peter.kistler@baker.edu.au.
Journal:JACC Clin Electrophysiol. 2022 Aug;8(8):1051-1059. doi: 10.1016/j.jacep.2021.12.008. Epub 2022 Feb 23.

11:Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives.
Authors:Gonçalves-Teixeira P, Costa T, Fragoso I, Ferreira D, Brandão M, Leite-Moreira A, Sampaio F, Ribeiro J, Fontes-Carvalho R
Institution:Departamento de Cardiologia, Vila Nova de Gaia Hospital Center, Gaia - Portugal.
Journal:Arq Bras Cardiol. 2022 Aug;119(2):328-341. doi: 10.36660/abc.20201362.

12:A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry.
Authors:Esteve-Pastor MA, Rivera-Caravaca JM, Ruiz-Ortiz M, Muñiz J, Roldán-Rabadán I, Otero D, López-Gálvez R, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F
Institution:Department of Cardiology, Hospital Clinico Universitario Virgen de la Arrixaca, Universidad de Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.
Journal:Expert Opin Pharmacother. 2022 Aug;23(12):1457-1465. doi: 10.1080/14656566.2022.2109961. Epub 2022 Aug 12.

13:Ultra-Low Temperature Cryoablation for Atrial Fibrillation: Primary Outcomes for Efficacy and Safety: The Cryocure-2 Study.
Authors:De Potter T, Klaver M, Babkin A, Iliodromitis K, Hocini M, Cox J, Boersma L
Institution:Cardiovascular Centre, OLV Aalst, Aalst, Belgium. Electronic address: tom.de.potter@olvz-aalst.be.; Cardiology Department, St. Antonius Hospital, Nieuwegein, the Netherlands; Cardiology Department, Amsterdam UMC, Amsterdam, the Netherlands.
Journal:JACC Clin Electrophysiol. 2022 Aug;8(8):1034-1039. doi: 10.1016/j.jacep.2022.05.017. Epub 2022 Jul 27.

14:Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
Authors:Reddy YNV, Borlaug BA, Gersh BJ
Institution:Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Journal:Circulation. 2022 Jul 26;146(4):339-357. doi: 10.1161/CIRCULATIONAHA.122.057444. Epub 2022 Jul 25.

15:Is Maintenance of Sinus Rhythm of Value in Patients with Atrial Fibrillation and Heart Failure?
Authors:Sadek MM, Skanes A, Tang ASL
Institution:Arrhythmia Service, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.; Schulich School of Medicine and Dentistry, Western University, University Hospital, 339 Windermere Road, London, ON, C6-116, Canada. anthonysltang@gmail.com.
Journal:Curr Cardiol Rep. 2022 Oct;24(10):1227-1231. doi: 10.1007/s11886-022-01743-z. Epub 2022 Jul 23.

16:Atrial Fibrillation and the Risk of Early-Onset Dementia: A Systematic Review and Meta-Analysis.
Authors:Giannone ME, Filippini T, Whelton PK, Chiari A, Vitolo M, Boriani G, Vinceti M
Institution:Department of Biomedical, Metabolic and Neural Sciences, Environmental, Genetic and Nutritional Epidemiology Research Center University of Modena and Reggio Emilia Modena Italy.
Journal:J Am Heart Assoc. 2022 Jul 19;11(14):e025653. doi: 10.1161/JAHA.122.025653. Epub 2022 Jul 15.

17:Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies.
Authors:Archontakis-Barakakis P, Li W, Kalaitzoglou D, Tzelves L, Manolopoulos A, Giannopoulos S, Giamouzis G, Giannakoulas G, Batsidis A, Palaiodimos L, Ntaios G, Lip GYH, Kokkinidis DG
Institution:Northeast Internal Medicine Associates, LaGrange, IN, USA.; Section of Cardiovascular Medicine, Yale University School of Medicine, Yale New Haven Hospital, New Haven, CT, USA.
Journal:Br J Clin Pharmacol. 2022 Nov;88(11):4663-4675. doi: 10.1111/bcp.15464. Epub 2022 Aug 15.

18:Cryoballoon ablation beyond pulmonary vein isolation in the setting of persistent atrial fibrillation.
Authors:Miraglia V, Bisignani A, Pannone L, Iacopino S, Chierchia GB, de Asmundis C
Institution:Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
Journal:Expert Rev Med Devices. 2022 May;19(5):431-439. doi: 10.1080/17434440.2022.2096437. Epub 2022 Jul 18.

19:Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients.
Authors:Koniari I, Artopoulou E, Velissaris D, Mplani V, Anastasopoulou M, Kounis N, de Gregorio C, Tsigkas G, Karunakaran A, Plotas P, Ikonomidis I
Institution:Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester M23 9LT, UK.; Second Cardiology Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Journal:Medicina (Kaunas). 2022 May 30;58(6):743. doi: 10.3390/medicina58060743.

20:Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes.
Authors:Gunawardene MA, Willems S
Institution:Department of Cardiology and Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Journal:Europace. 2022 Jun 6;24(Supplement_2):ii22-ii28. doi: 10.1093/europace/euab257.

21:In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation.
Authors:Peng TJ, Viscoli C, Khatri P, Wolfe SQ, Bhatt NR, Girotra T, Kamel H, Sheth KN
Institution:Department of Neurology, Yale University School of Medicine, 15 York Street LCI, 1003C, New Haven, CT, 06510, USA. Kevin.sheth@yale.edu.
Journal:Drugs. 2022 Jun;82(9):965-977. doi: 10.1007/s40265-022-01729-9. Epub 2022 Jun 3.

22:Effect of catheter ablation combined with left appendage occlusion for non-valvular atrial fibrillation: a meta-analysis.
Authors:Qu J, Wang Z, Wang S
Institution:Department of Internal Medicine-Cardiovascular, YanTai YuHuangDing Hospital, Yantai, Shandong, China.; Department of Internal Medicine-Cardiovascular, LiaoCheng People's Hospital, No. 67, Dongchang West Road, Liaocheng, 252000, Shandong, China. zwj131378@126.com.
Journal:J Cardiothorac Surg. 2022 May 31;17(1):132. doi: 10.1186/s13019-022-01885-9.

23:Pulsed Field Ablation: a Novel Therapeutic Tool for Catheter-Based Treatment of Atrial Fibrillation.
Authors:Darby AE
Institution:Department of Medicine, Cardiology Division, University of Virginia Health System: UVA Health, Charlottesville, VA, USA. aed6d@virginia.edu.
Journal:Curr Cardiol Rep. 2022 Jul;24(7):793-799. doi: 10.1007/s11886-022-01697-2. Epub 2022 May 24.

24:The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
Authors:Camm AJ, Naccarelli GV, Mittal S, Crijns HJGM, Hohnloser SH, Ma CS, Natale A, Turakhia MP, Kirchhof P
Institution:Cardiovascular Clinical Academic Group, St George's University of London, London, United Kingdom. Electronic address: jcamm@sgul.ac.uk.; Department of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Luebeck, Berlin, Germany; Atrial Fibrillation Network (AFNET), Munster, Germany; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Journal:J Am Coll Cardiol. 2022 May 17;79(19):1932-1948. doi: 10.1016/j.jacc.2022.03.337.

25:Anemia and iron deficiency in patients with atrial fibrillation.
Authors:Hanna-Rivero N, Tu SJ, Elliott AD, Pitman BM, Gallagher C, Lau DH, Sanders P, Wong CX
Institution:Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia. c.wong@adelaide.edu.au.
Journal:BMC Cardiovasc Disord. 2022 May 4;22(1):204. doi: 10.1186/s12872-022-02633-6.

26:Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.
Authors:Obeidat M, Burgess M, Lip GYH
Institution:Department of Cardiology, Aintree Hospital, Liverpool, UK.; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: gregory.lip@liverpool.ac.uk.
Journal:Cardiol Clin. 2022 May;40(2):245-258. doi: 10.1016/j.ccl.2021.12.012.

27:Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease.
Authors:Dawwas GK, Barnes GD
Institution:Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gkdawwas@pennmedicine.upenn.edu.; Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Health System, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd, Building #14, Room G214, Ann Arbor, MI, 48109, USA.
Journal:Curr Cardiol Rep. 2022 Jun;24(6):731-738. doi: 10.1007/s11886-022-01690-9. Epub 2022 Apr 23.

28:Mechanisms and Therapeutic Opportunities in Atrial Fibrillation in Relationship to Alcohol Use and Abuse.
Authors:Linz B, Hertel JN, Jespersen T, Linz D
Institution:Faculty of Health and Medical Sciences, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: dominik.linz@mumc.nl.
Journal:Can J Cardiol. 2022 Sep;38(9):1352-1363. doi: 10.1016/j.cjca.2022.04.009. Epub 2022 Apr 15.

29:Genetic and non-genetic risk factors associated with atrial fibrillation.
Authors:Young LJ, Antwi-Boasiako S, Ferrall J, Wold LE, Mohler PJ, El Refaey M
Institution:The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA; Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH, USA.; The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA; Department of Surgery, Division of Cardiac Surgery, The Ohio State University, Columbus, OH, USA. Electronic address: Mona.elrefaey@osumc.edu.
Journal:Life Sci. 2022 Jun 15;299:120529. doi: 10.1016/j.lfs.2022.120529. Epub 2022 Apr 3.

30:Effects of chronically skipping meals on atrial fibrillation risk.
Authors:Nizami H, Su L, Jain R, Jain R
Institution:School of Medicine, American University of Integrative Sciences, #9 5th Avenue Belleville, St. Michael, Barbados.; Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.
Journal:Future Cardiol. 2022 Jun;18(6):497-506. doi: 10.2217/fca-2021-0086. Epub 2022 Apr 1.

31:Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies.
Authors:Lacoste JL, Szymanski TW, Avalon JC, Kabulski G, Kohli U, Marrouche N, Singla A, Balla S, Jahangir A
Institution:Department of Pharmacy, WVU Medicine, 1 Medical Center Drive, Morgantown, WV, 26505, USA. Jordan.Lacoste.m@wvumedicine.org.; Center for Advanced Atrial Fibrillation Therapies at Aurora St. Luke's Medical Center, Milwaukee, WI, 53215, USA.
Journal:Am J Cardiovasc Drugs. 2022 Sep;22(5):475-496. doi: 10.1007/s40256-022-00529-6. Epub 2022 Mar 30.

32:Catheter ablation of atrial fibrillation: Current status and near future.
Authors:Yamane T
Institution:Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. Electronic address: yamanet1@aol.com.
Journal:J Cardiol. 2022 Jul;80(1):22-27. doi: 10.1016/j.jjcc.2022.02.005. Epub 2022 Feb 24.

33:The connubium among diabetes, chronic kidney disease and atrial fibrillation.
Authors:Magnocavallo M, Vetta G, Trivigno S, Mariani MV, DI Lullo L, Bellasi A, Della Rocca DG, Severino P, Piro A, Giunta G, Quaglione R, Lavalle C
Institution:Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University, Rome, Italy.; Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University, Rome, Italy - carlo.lavalle@uniroma1.it.
Journal:Minerva Cardiol Angiol. 2022 Jun;70(3):393-402. doi: 10.23736/S2724-5683.22.05891-4. Epub 2022 Feb 25.

34:Atrial fibrillation and stroke: importance of left atrium as assessed by echocardiography.
Authors:Suwa Y, Miyasaka Y, Taniguchi N, Harada S, Nakai E, Shiojima I
Institution:Division of Cardiology, Department of Medicine II, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
Journal:J Echocardiogr. 2022 Jun;20(2):69-76. doi: 10.1007/s12574-021-00561-6. Epub 2022 Jan 23.

35:Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people.
Authors:Erdem G, Esme M, Doğu BB
Institution:London School of Economics and Political Sciences, London, UK.; Department of Internal Medicine, Division of Geriatric Medicine, Hacettepe University, Ankara, Turkey.
Journal:Ir J Med Sci. 2022 Dec;191(6):2517-2523. doi: 10.1007/s11845-021-02891-x. Epub 2022 Jan 21.

36:Atrial Fibrillation Following Coronary Artery Bypass Graft: Where Do We Stand?
Authors:Tzoumas A, Nagraj S, Tasoudis P, Arfaras-Melainis A, Palaiodimos L, Kokkinidis DG, Kampaktsis PN
Institution:Aristotle University of Thessaloniki, Thessaloniki 541 24, Greece.; Division of Cardiology, New York University Langone Medical Center, 550 1st Ave, New York, NY, USA.
Journal:Cardiovasc Revasc Med. 2022 Jul;40:172-179. doi: 10.1016/j.carrev.2021.12.006. Epub 2021 Dec 16.

37:Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms.
Authors:Burashnikov A
Institution:Lankenau Institute for Medical Research, Wynnewood, PA; and.
Journal:J Cardiovasc Pharmacol. 2022 Oct 1;80(4):540-546. doi: 10.1097/FJC.0000000000001182.

38:The efficacy and safety of insertable cardiac monitor on atrial fibrillation detection in patients with ischemic stroke: a systematic review and meta-analysis.
Authors:Tan X, Wang Z, Wu X, Zhang J, Song Z, Qiu Y, Chen Z, Wang Z, Chen G
Institution:Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China.
Journal:J Neurol. 2022 May;269(5):2338-2345. doi: 10.1007/s00415-021-10903-0. Epub 2021 Nov 20.

39:Stroke prevention in atrial fibrillation.
Authors:Lip GYH, Gue Y, Zhang J, Chao TF, Calkins H, Potpara T
Institution:Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: gregory.lip@liverpool.ac.uk.; School of Medicine, Belgrade University; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia.
Journal:Trends Cardiovasc Med. 2022 Nov;32(8):501-510. doi: 10.1016/j.tcm.2021.10.001. Epub 2021 Oct 5.

40:Rate and Rhythm Control Treatment in the Elderly and Very Elderly Patients With Atrial Fibrillation: An Observational Cohort Study of 1497 Patients.
Authors:Klamer TA, Bots SH, Neefs J, Tulevski II, Ruijter HMD, Somsen GA, de Groot JR
Institution:Department of Cardiology, Amsterdam UMC, University of Amsterdam, Heart Center, Amsterdam, The Netherlands. Electronic address: j.r.degroot@amsterdamumc.nl.
Journal:Curr Probl Cardiol. 2022 Oct;47(10):100996. doi: 10.1016/j.cpcardiol.2021.100996. Epub 2021 Oct 2.

41:Pulsed field catheter ablation in atrial fibrillation.
Authors:Di Biase L, Diaz JC, Zhang XD, Romero J
Institution:Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx 10467, NY, United States. Electronic address: dibbia@gmail.com.
Journal:Trends Cardiovasc Med. 2022 Aug;32(6):378-387. doi: 10.1016/j.tcm.2021.07.006. Epub 2021 Jul 28.

42:Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions.
Authors:Tsigkas G, Apostolos A, Despotopoulos S, Vasilagkos G, Kallergis E, Leventopoulos G, Mplani V, Davlouros P
Institution:Department of Cardiology, University Hospital of Patras, Patras, Greece. gregtsig@hotmail.com.
Journal:Heart Fail Rev. 2022 Jul;27(4):1201-1210. doi: 10.1007/s10741-021-10133-6. Epub 2021 Jul 4.

For a FREE PREVIEW of the Medifocus Guidebook on Atrial Fibrillation click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Atrial Fibrillation click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Atrial Fibrillation...
at a Special 20% Discount


Medifocus Guidebook on Atrial Fibrillation

Updated: January 10, 2023
160 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Atrial Fibrillation is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $37.45
  • Less 20% Discount = - $7.10
  • Discounted Price = $30.35(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $31.20
  • Less 20% Discount = - $6.45
  • Discounted Price = $24.75

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

AF441023329

Coupon Expires: March 9, 2023



What Our Customers Are Saying...

"The MediFocus Guidebook on Atrial Fibrillation has enhanced and clearly explained this condition for me. It has also enabled me to make choices with confidence regarding my treatment. The references in the medical literature section has put me in touch with the research base in this country. Many thanks."
E.B.
Seaford, East Sussex


"I found the MediFocus Guidebook on Atrial Fibrillation extremely informative and very easy to understand. As a result of the information in the Guidebook, I'm able to discuss my problem with my doctor in a more informed manner and make better decisions regarding treatment."
J.T.F.
Agoura Hills, California


"The Medifocus Guidebook on Atrial Fibrillation gave me far more information than was available from my doctor and helped me understand my condition."
C.B.
Rancho Santa Fe, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2023 Medifocus, Inc. All rights reserved.